Co-Delivery of Curcumin and Paclitaxel by “Core-Shell” Targeting Amphiphilic Copolymer to Reverse Resistance in the Treatment of Ovarian Cancer

Co-Delivery of Curcumin and Paclitaxel by “Core-Shell” Targeting Amphiphilic Copolymer to Reverse Resistance in the Treatment of Ovarian Cancer

Meng-Dan Zhao,1 Jun-Qin Li,2 Feng-Ying Chen,1 Wei Dong,3 Li-Juan Wen,4 Wei-Dong Fei,1 Xiao Zhang,1 Pei-Lei Yang,1 Xin-Mei Zhang,2 Cai-Hong Zheng1 1Department of Pharmacy, Women’s Hospital, Zhejiang University School of Medicine, Hangzhou 310006, People’s Republic of China; 2Depar...

Full description

Bibliographic Details
Main Authors: Zhao MD, Li JQ, Chen FY, Dong W, Wen LJ, Fei WD, Zhang X, Yang PL, Zhang XM, Zheng CH
Format: Article
Language:English
Published: Dove Medical Press 2019-12-01
Series:International Journal of Nanomedicine
Subjects:
co-delivery
curcumin
reverses resistance
paclitaxel
ovarian cancer
adverse reactions
Online Access:https://www.dovepress.com/co-delivery-of-curcumin-and-paclitaxel-by-ldquocore-shellrdquo-targeti-peer-reviewed-article-IJN

Internet

https://www.dovepress.com/co-delivery-of-curcumin-and-paclitaxel-by-ldquocore-shellrdquo-targeti-peer-reviewed-article-IJN

Similar Items